Not a problem. If it seems as if the lead was taken from BioHeart it will only be regained once they announce complete enrollment of phase 3 mirror trial for Myocell.
That's most likely because Bioheart has been under the radar IMO. Also, Mesoblast has been in the news lately stating the "largest trial" has begun, etc. The reason it is so large is because since they are using Allogeneic stem cells they need a greater sample size to demonstrate safety.
News 
Market Data 
Discover 
AI
